SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062234
Filing Date
2023-11-09
Accepted
2023-11-09 17:17:58
Documents
18
Period of Report
2023-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20231109.htm   iXBRL 8-K 66082
2 FORM OF NEW SERIES A-1 WARRANT apvo-ex4_1.htm EX-4.1 172006
3 FORM OF NEW SERIES A-2 WARRANT apvo-ex4_2.htm EX-4.2 189029
4 FORM OF NEW SERIES B-1 WARRANT apvo-ex4_3.htm EX-4.3 172197
5 FORM OF NEW SERIES B-2 WARRANT apvo-ex4_4.htm EX-4.4 184318
6 FORM OF WARRANT INDUCEMENT AGREEMENT, BY AND BETWEEN THE COMPANY AND EACH HOLDER apvo-ex10_1.htm EX-10.1 153191
7 FINANCIAL ADVISORY AGREEMENT apvo-ex10_2.htm EX-10.2 61957
  Complete submission text file 0000950170-23-062234.txt   1256693

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apvo-20231109_pre.xml EX-101.PRE 10302
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apvo-20231109_lab.xml EX-101.LAB 14028
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apvo-20231109.xsd EX-101.SCH 2487
12 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20231109_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 231393792
SIC: 2834 Pharmaceutical Preparations